- Home
- PBBK vs ALGS Comparison
PBBK vs ALGS Comparison
Compare PBBK & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBBK
- ALGS
- Stock Information
- Founded
- PBBK 1919
- ALGS 2018
- Country
- PBBK United States
- ALGS United States
- Employees
- PBBK N/A
- ALGS N/A
- Industry
- PBBK Banks
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- PBBK Finance
- ALGS Health Care
- Exchange
- PBBK Nasdaq
- ALGS Nasdaq
- Market Cap
- PBBK 45.2M
- ALGS 53.0M
- IPO Year
- PBBK N/A
- ALGS 2020
- Fundamental
- Price
- PBBK $18.43
- ALGS $9.13
- Analyst Decision
- PBBK
- ALGS Strong Buy
- Analyst Count
- PBBK 0
- ALGS 1
- Target Price
- PBBK N/A
- ALGS $70.00
- AVG Volume (30 Days)
- PBBK 29.2K
- ALGS 85.7K
- Earning Date
- PBBK 07-23-2025
- ALGS 08-05-2025
- Dividend Yield
- PBBK N/A
- ALGS N/A
- EPS Growth
- PBBK 41.93
- ALGS N/A
- EPS
- PBBK 0.95
- ALGS N/A
- Revenue
- PBBK $13,359,000.00
- ALGS $3,270,000.00
- Revenue This Year
- PBBK N/A
- ALGS N/A
- Revenue Next Year
- PBBK N/A
- ALGS $51.55
- P/E Ratio
- PBBK $19.35
- ALGS N/A
- Revenue Growth
- PBBK 12.31
- ALGS N/A
- 52 Week Low
- PBBK $14.05
- ALGS $3.76
- 52 Week High
- PBBK $19.12
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- PBBK 56.52
- ALGS 59.79
- Support Level
- PBBK $18.19
- ALGS $8.18
- Resistance Level
- PBBK $18.51
- ALGS $9.44
- Average True Range (ATR)
- PBBK 0.26
- ALGS 0.71
- MACD
- PBBK -0.07
- ALGS 0.01
- Stochastic Oscillator
- PBBK 34.29
- ALGS 65.95
About PBBK PB Bankshares Inc.
PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.